Main Industry
Biotechnology
Main Product/Service
The core products and services of GlycoGenetics include: recombinant human lectin reagents for cell‑surface glycoprofiling; lectin array and flow cytometry platforms for glycan characteristic analysis; and discovery services for biomarkers and drug target
The content above was translated by Ai
Founded Year
2017
Unified Business No.
55688209
Status
Active
Number of Employees
0
Total Paid-in
Capital
500,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
GlycoGenetics, Inc., founded in 2017 and headquartered in Zhongshan District, Taipei City, Taiwan, is a biotechnology company focused on glycobiology. Leveraging genetic engineering and synthetic biology, the company deciphers the complex glycocode of human biology and develops molecular tools and platforms to accelerate the application of glycomics in basic research, clinical diagnostics and bioprocessing.
The content above was translated by Ai